[Protein kinase CK2 and human malignant tumors]
- PMID: 22814265
- PMCID: PMC6000077
- DOI: 10.3779/j.issn.1009-3419.2012.07.09
[Protein kinase CK2 and human malignant tumors]
Similar articles
-
Protein kinase CK2: a catalyst for biology, medicine and structural biochemistry.Mol Cell Biochem. 2011 Oct;356(1-2):1-3. doi: 10.1007/s11010-011-0940-0. Epub 2011 Jul 15. Mol Cell Biochem. 2011. PMID: 21761205 No abstract available.
-
Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.Cell Mol Life Sci. 2009 Jun;66(11-12):1858-67. doi: 10.1007/s00018-009-9154-y. Cell Mol Life Sci. 2009. PMID: 19387548 Free PMC article. Review.
-
Protein kinase CK2 inhibition as a pharmacological strategy.Adv Protein Chem Struct Biol. 2021;124:23-46. doi: 10.1016/bs.apcsb.2020.09.003. Epub 2021 Jan 9. Adv Protein Chem Struct Biol. 2021. PMID: 33632467 Review.
-
Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library.BMC Cancer. 2009 May 6;9:135. doi: 10.1186/1471-2407-9-135. BMC Cancer. 2009. PMID: 19419583 Free PMC article.
-
ATP site-directed inhibitors of protein kinase CK2: an update.Curr Top Med Chem. 2011;11(11):1340-51. doi: 10.2174/156802611795589638. Curr Top Med Chem. 2011. PMID: 21513497 Review.
References
-
- Ilhol O, Cochet C. Protein kinase CK2 and cancer: further clues are accumulating. https://www.researchgate.net/publication/11426816_Protein_kinase_CK2_and.... Bull Cancer. 2002;89(3):261–265. - PubMed